Response to: 'is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?' by Fleishman and Yazici
- PMID: 24962874
- DOI: 10.1136/annrheumdis-2014-205938
Response to: 'is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?' by Fleishman and Yazici
Keywords: Methotrexate; Rheumatoid Arthritis; Treatment.
Comment on
-
Head-to-head, randomised, crossover study of oral versus subcutaneous methotrexate in patients with rheumatoid arthritis: drug-exposure limitations of oral methotrexate at doses ≥15 mg may be overcome with subcutaneous administration.Ann Rheum Dis. 2014 Aug;73(8):1549-51. doi: 10.1136/annrheumdis-2014-205228. Epub 2014 Apr 12. Ann Rheum Dis. 2014. PMID: 24728329 Free PMC article. Clinical Trial.
-
Is there a direct relationship between serum level of methotrexate and clinical efficacy and tolerability?Ann Rheum Dis. 2014 Sep;73(9):e54. doi: 10.1136/annrheumdis-2014-205901. Epub 2014 Jun 3. Ann Rheum Dis. 2014. PMID: 24894190 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
